Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(4):247-248; doi:10.1093/jnci/97.4.247
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Hede, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hede, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

NEWS

NCI's National Biospecimen Network: Too Early or Too Late?

Karyn Hede

The first 150 words of the full text of this article appear below.

The genomic revolution has been heralded as the gateway to personalized medicine, but to make those promises a reality, medical researchers are realizing that they will need access to patient specimens and detailed patient data on a scale never before assembled. The concept of banking patient tissue for research is hardly new; there are some 300 million specimens preserved in biobanks throughout the United States managed by clinical trials cooperative groups, academic institutions, and individual investigators.

The National Cancer Institute has been working since 2002 to unify these biobanks through its planned National Biospecimen Network (NBN), but progress has been slow relative to that in other nations, and future funding for the project has yet to be identified.

The bold mandate issued for the NBN in its "blueprint" calls for a nationwide system of regional biospecimen repositories united under a single management that uses a single bioinformatics and tissue collection . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 aacredbookHome page
P. Maruvada and S. Srivastava
Joint National Cancer Institute-Food and Drug Administration Workshop on Research Strategies, Study Designs, and Statistical Approaches to Biomarker Validation for Cancer Diagnosis and Detection
Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 239 - 247.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
P. Maruvada and S. Srivastava
Joint national cancer institute-food and drug administration workshop on research strategies, study designs, and statistical approaches to biomarker validation for cancer diagnosis and detection.
Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1078 - 1082.
[Abstract] [Full Text] [PDF]